Neuren Pharmaceuticals is a biopharmaceutical company focused on developing treatments for neurodevelopmental disorders, including Rett syndrome and Fragile X syndrome.
No data available
Are you interested in the impact of this stock or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!